The highly anticipated innovative Retatrutide 20mg injector is now becoming available in the UK. As of now, access is controlled and primarily by specialist centers participating in clinical programs. While a full, general commercial launch date remains tentative, initial reports that those eligible will be able to receive the drug via specialist r